KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company ShowcaseBusiness Wire • 09/15/23
KORU Medical Systems Inc. (KRMD) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/09/23
KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 OutlookBusiness Wire • 08/09/23
KORU Medical Systems to Participate in the Genuity 43rd Annual Growth ConferenceBusiness Wire • 08/08/23
KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive UpdatesBusiness Wire • 08/02/23
KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023Business Wire • 07/31/23
KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological BiologicBusiness Wire • 07/27/23
KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled SyringesBusiness Wire • 07/10/23
Will KORU Medical Systems Inc. (KRMD) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 04/27/23
KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023Business Wire • 04/21/23
KORU Medical Systems Inc. (KRMD) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/08/23
KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022Business Wire • 03/08/23
KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023Business Wire • 02/22/23
KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development AgreementBusiness Wire • 01/25/23
KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare ConferenceBusiness Wire • 11/21/22
KORU Medical Systems Inc. (KRMD) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/09/22
KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira PharmaceuticalsBusiness Wire • 11/08/22